发明名称 Normal;heading 1;heading 2;heading 3;OXADIAZOLE DERIVATIVES ACTIVE ON SPHINGOSINE-1-PHOSPHATE (S1P)
摘要 The present application discloses oxadiazole based compounds of Formula (I) active on sphingosine-1-phosphate (SIP) in particular useful to treat lupus erythematosus. A is phenyl or a 5 or 6-membered heteroaryl ring; Ris up to two substituents independently selected from halogen, Calkoxy, Cfluoroalkyl, cyano, optionally substituted phenyl, Cfluoroalkoxy, Calkyl and Ccyctoalkyl; Ris hydrogen, halogen or Calkyl; B is a 7 membered saturated ring selected from the formulae (a) (b) (c), Ris hydrogen or (CH)MCOH; Ris hydrogen or Calkyl optionally interrupted by oxygen.
申请公布号 UA101349(C2) 申请公布日期 2013.03.25
申请号 UA20100009202 申请日期 2008.12.19
申请人 GLAXO GROUP LIMITED 发明人 DEMONT, EMMANUEL, HUBERT;HEER, JAG, PAUL;HEIGHTMAN, THOMAS, DANIEL;HURST, DAVID, NIGEL;JOHNSON CHRISTOPHER NORBERT;SKIDMORE, JOHN;WALL, IAN, DAVID;WITHERINGTON, JASON
分类号 C07D413/04;A61K31/55;C07D271/06;C07D413/14 主分类号 C07D413/04
代理机构 代理人
主权项
地址